Skip to main content
GENB logo

GENB · Generate Biomedicines, Inc.

$13.40 -0.43 (-3.11%) At close · Jul 24
Market Cap
$1.77B
Shares
128.19M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers twice a month. Each reading settles on the 15th and the last business day of the month and is published seven business days later — the next scheduled dates are listed at the top of the table. Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
70/100
Short interest 5.4% of shares — P75 Days to cover 9.4 — P89 Price vs VWAP -4.9% — P39 Short-volume trend +8.6% — P73 Short interest change +18.1% — P81 Worst FTD 0.02% of shares — P53

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-15). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-08-14 Scheduled
FINRA publishes Aug 25
2026-07-31 Scheduled
FINRA publishes Aug 11
2026-07-15 6,985,520 5,916,840 +1,068,680 9.38
2026-06-30 5,916,840 4,548,820 +1,368,020 4.03
2026-06-15 4,548,820 4,087,393 +461,427 4.84
2026-05-29 4,087,393 3,453,784 +633,609 4.84
2026-05-15 3,453,784 3,178,648 +275,136 8.54
2026-04-30 3,178,648 2,078,055 +1,100,593 9.69
2026-04-15 2,078,055 1,362,198 +715,857 5.88
2026-03-31 1,362,198 893,427 +468,771 3.90
2026-03-13 893,427 0 +893,427 1.00
Showing 1–9 of 9 settlements
Key facts CIK 2100782 CUSIP 370920100 13F (30d) 4 filings 4 filers Visit website